We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News > Cultivation > Content Piece

DEA Awards Seventh Cannabis Cultivation License For Research Purposes

By Leo Bear-McGuinness

Published: Aug 22, 2022   

Complete the form below and we will email you a PDF version of "DEA Awards Seventh Cannabis Cultivation License For Research Purposes"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

DEA Awards Seventh Cannabis Cultivation License For Research Purposes

The US’s Drug Enforcement Administration (DEA) and the Department of Justice have licensed the company Maridose to produce cannabis for research purposes.

The Maine-based company is the seventh to receive such a license “for the bulk manufacture of cannabis to supply marijuana, cannabis extracts and THC to researchers.”

New cultivators, new crops

For decades, the sole source of cannabis for scientific research in the United States has been a single cultivation facility operated at the University of Mississippi.

In 2016, the Obama administration announced that the DEA would begin accepting applications to approve additional manufacturers, but no approvals were ever made during the Trump administration.

In 2021, under the Biden administration, the DEA finally awarded new bulk manufacturing licenses to four other organizations, including the Scottsdale Research Institute and Royal Emerald Pharmaceuticals.

Earlier this year, the federal agency also licensed Irvine Labs in Huntington Beach, California. Maridose's successful bid marks the seventh such license.

“We are very excited to receive this license from the DEA to produce and sell cannabis for research purpose, this a huge step for science and the future of cannabis,” Richard Shain, Maridose’s founder, said in a statement.

“Our DEA Registration NumberRM063095 is the culmination of over five years of working with the DEA and enables Maridose to legally sell a wide variety of cannabis products through the DEA to researchers and DEA-licensed pharmaceutical companies in the United States and internationally.”

“The DEA has indicated that it will only issue a very limited number of them, and Maridose is proud to be one of the first companies to receive a license.”

 

Like what you just read? You can find similar content on the topic tags shown below.

Cultivation Policy Science & Health

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement